These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36109362)

  • 21. Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes.
    Dunbar KB; Agoston AT; Odze RD; Huo X; Pham TH; Cipher DJ; Castell DO; Genta RM; Souza RF; Spechler SJ
    JAMA; 2016 May; 315(19):2104-12. PubMed ID: 27187303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endoscopic full-thickness plication for the treatment of PPI-dependent GERD: results from a randomised, sham controlled trial.
    Kalapala R; Karyampudi A; Nabi Z; Darisetty S; Jagtap N; Ramchandani M; Gupta R; Lakhtakia S; Goud R; Venkat Rao G; Sharma P; Reddy DN
    Gut; 2022 Apr; 71(4):686-694. PubMed ID: 33849942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evaluation of recumbent reflux by multichannel intraluminal impedance pH testing for patients with gastroesophageal reflux disease and sleep disturbance.
    Hoshino M; Omura N; Yano F; Tsuboi K; Yamamoto SR; Akimoto S; Masuda T; Kashiwagi H; Yanaga K
    Esophagus; 2020 Jul; 17(3):348-354. PubMed ID: 31970574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.
    Galindo G; Vassalle J; Marcus SN; Triadafilopoulos G
    Dis Esophagus; 2013 Jul; 26(5):443-50. PubMed ID: 22862422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New treatment method for refractory gastroesophageal reflux disease (GERD): C-BLART (clip band ligation anti-reflux therapy)-a short-term study.
    Liu S; Chai N; Zhai Y; Zou J; Feng X; Li Z; Li L; Zhang X; Wang X; Wang S; Linghu EQ
    Surg Endosc; 2020 Oct; 34(10):4516-4524. PubMed ID: 31728750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Longitudinal study of gastroesophageal reflux and erosive tooth wear.
    Wilder-Smith CH; Materna A; Martig L; Lussi A
    BMC Gastroenterol; 2017 Oct; 17(1):113. PubMed ID: 29070010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adding Acotiamide to Gastric Acid Inhibitors Is Effective for Treating Refractory Symptoms in Patients with Non-erosive Reflux Disease.
    Yamashita H; Okada A; Naora K; Hongoh M; Kinoshita Y
    Dig Dis Sci; 2019 Mar; 64(3):823-831. PubMed ID: 30465175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impedance-pH Monitoring for Diagnosis of Reflux Disease: New Perspectives.
    Frazzoni M; de Bortoli N; Frazzoni L; Tolone S; Savarino V; Savarino E
    Dig Dis Sci; 2017 Aug; 62(8):1881-1889. PubMed ID: 28550489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effects of Switching to Vonoprazan, a Novel Potassium-Competitive Acid Blocker, on Gastric Acidity and Reflux Patterns in Patients with Erosive Esophagitis Refractory to Proton Pump Inhibitors.
    Yamashita H; Kanamori A; Kano C; Hashimura H; Matsumoto K; Tsujimae M; Yoshizaki T; Momose K; Obata D; Eguchi T; Fujita M; Okada A
    Digestion; 2017; 96(1):52-59. PubMed ID: 28662503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Gastroesophageal Reflux by Combined Multichannel Intraluminal Impedance and pH Monitoring and Esophageal Motility Patterns in Children with Esophageal Atresia.
    Tong S; Mallitt KA; Krishnan U
    Eur J Pediatr Surg; 2016 Aug; 26(4):322-31. PubMed ID: 26445355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Correlation between Endoscopic Reflux Esophagitis and Combined Multichannel Intraluminal Impedance-pH Monitoring in Children.
    Liu YW; Wu JF; Chen HL; Hsu HY; Chang MH; Hsu WC; Tseng PH; Wang HP; Ni YH
    Pediatr Neonatol; 2016 Oct; 57(5):385-389. PubMed ID: 26803582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease.
    Ranaldo N; Losurdo G; Iannone A; Principi M; Barone M; De Carne M; Ierardi E; Di Leo A
    Cell Death Dis; 2017 Sep; 8(9):e3040. PubMed ID: 28880273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of pH Impedance Monitoring While on Twice-Daily Proton Pump Inhibitor Therapy to Identify Need for Escalation of Reflux Management.
    Gyawali CP; Tutuian R; Zerbib F; Rogers BD; Frazzoni M; Roman S; Savarino E; de Bortoli N; Vela MF; Sifrim D
    Gastroenterology; 2021 Nov; 161(5):1412-1422. PubMed ID: 34270955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. More severe upper gastrointestinal symptoms associated with non-erosive reflux disease than with erosive gastroesophageal reflux disease during maintenance proton pump inhibitor therapy.
    Kusano M; Hosaka H; Kawamura O; Kawada A; Kuribayashi S; Shimoyama Y; Yasuoka H; Mizuide M; Tomizawa T; Sagawa T; Sato K; Yamada M
    J Gastroenterol; 2015 Mar; 50(3):298-304. PubMed ID: 24919745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent Postprandial Regurgitation vs Rumination in Patients With Refractory Gastroesophageal Reflux Disease Symptoms: Identification of a Distinct Rumination Pattern Using Ambulatory Impedance-pH Monitoring.
    Nakagawa K; Sawada A; Hoshikawa Y; Nikaki K; Sonmez S; Woodland P; Yazaki E; Sifrim D
    Am J Gastroenterol; 2019 Aug; 114(8):1248-1255. PubMed ID: 31246694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of baseline impedance in patients with proton pump inhibitor-refractory nonerosive reflux disease.
    Kohata Y; Fujiwara Y; Yamagami H; Tanigawa T; Shiba M; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():36-40. PubMed ID: 25827802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
    Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical role of ambulatory reflux monitoring in PPI non-responders: recommendation statements.
    Yadlapati R; Gawron AJ; Gyawali CP; Chen J; Clarke J; Fass R; Jain A; Lynch K; Khan A; Katz PO; Katzka DA; Richter J; Schnoll-Sussman F; Spechler SJ; Vaezi MF; Vela M; Pandolfino JE
    Aliment Pharmacol Ther; 2022 Oct; 56(8):1274-1283. PubMed ID: 35971888
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of baseline impedance as a marker of mucosal integrity in children with gastro esophageal reflux disease.
    Pilic D; Hankel S; Koerner-Rettberg C; Hamelmann E; Schmidt-Choudhury A
    Scand J Gastroenterol; 2013 Jul; 48(7):785-93. PubMed ID: 23795658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proton pump inhibitors for reflux therapy in infants: effectiveness determined by impedance pH monitoring.
    Castellani C; Huber-Zeyringer A; Bachmaier G; Saxena AK; Höllwarth ME
    Pediatr Surg Int; 2014 Apr; 30(4):381-5. PubMed ID: 24488061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.